The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
7-(4-(2-(4-(N-(6-chloropyrazin-2-yl)sulfamoyl)phenylamino)-2-oxoethyl)piperazin-1-yl)-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid ID: ALA5086519
PubChem CID: 166632883
Max Phase: Preclinical
Molecular Formula: C29H27ClFN7O6S
Molecular Weight: 656.10
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: O=C(CN1CCN(c2cc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1)Nc1ccc(S(=O)(=O)Nc2cncc(Cl)n2)cc1
Standard InChI: InChI=1S/C29H27ClFN7O6S/c30-25-13-32-14-26(34-25)35-45(43,44)19-5-1-17(2-6-19)33-27(39)16-36-7-9-37(10-8-36)24-12-23-20(11-22(24)31)28(40)21(29(41)42)15-38(23)18-3-4-18/h1-2,5-6,11-15,18H,3-4,7-10,16H2,(H,33,39)(H,34,35)(H,41,42)
Standard InChI Key: HOZCTRWTVFKGBZ-UHFFFAOYSA-N
Molfile:
RDKit 2D
45 50 0 0 0 0 0 0 0 0999 V2000
19.5177 -4.3955 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
19.9304 -3.6897 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
19.1128 -3.6852 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
27.0030 -2.9014 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.0019 -3.7209 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.7099 -4.1299 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.7081 -2.4925 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.4168 -2.8978 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.4156 -3.7230 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.1257 -4.1343 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
29.8415 -3.7250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.8427 -2.8999 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.1281 -2.4840 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.5514 -2.4930 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.2581 -2.9033 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
30.5534 -1.6758 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
29.1234 -4.9515 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.1281 -1.6668 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
28.7165 -5.6581 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.5337 -5.6604 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.2952 -2.4930 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
26.2939 -4.1290 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
25.5902 -3.7154 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.8843 -4.1199 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.8794 -4.9375 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
25.5866 -5.3488 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.2987 -4.9426 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.1698 -5.3428 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.4640 -4.9310 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.7544 -5.3363 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
22.0486 -4.9245 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.4677 -4.1138 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
22.0560 -4.1070 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.3510 -3.6953 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.6405 -4.1007 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.6393 -4.9221 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.3449 -5.3302 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.9367 -2.8726 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
19.2322 -2.4585 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.2406 -1.6431 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.5370 -1.2291 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
17.8251 -1.6323 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.8214 -2.4537 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.5257 -2.8640 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
17.1119 -2.8593 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 2 0
4 5 2 0
5 6 1 0
6 9 2 0
8 7 2 0
7 4 1 0
8 9 1 0
8 13 1 0
9 10 1 0
10 11 1 0
11 12 2 0
12 13 1 0
12 14 1 0
14 15 1 0
14 16 2 0
10 17 1 0
13 18 2 0
19 17 1 0
20 19 1 0
17 20 1 0
4 21 1 0
5 22 1 0
22 23 1 0
22 27 1 0
23 24 1 0
24 25 1 0
25 26 1 0
26 27 1 0
25 28 1 0
28 29 1 0
29 30 1 0
30 31 1 0
29 32 2 0
31 33 2 0
33 34 1 0
34 35 2 0
35 36 1 0
36 37 2 0
37 31 1 0
35 2 1 0
2 38 1 0
38 39 1 0
39 40 2 0
40 41 1 0
41 42 2 0
42 43 1 0
43 44 2 0
44 39 1 0
43 45 1 0
M END Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 656.10Molecular Weight (Monoisotopic): 655.1416AlogP: 3.18#Rotatable Bonds: 9Polar Surface Area: 166.83Molecular Species: ACIDHBA: 10HBD: 3#RO5 Violations: 1HBA (Lipinski): 13HBD (Lipinski): 3#RO5 Violations (Lipinski): 2CX Acidic pKa: 5.66CX Basic pKa: 4.64CX LogP: 2.02CX LogD: -0.32Aromatic Rings: 4Heavy Atoms: 45QED Weighted: 0.24Np Likeness Score: -1.64
References 1. Ibrahim NM, Fahim SH, Hassan M, Farag AE, Georgey HH.. (2022) Design and synthesis of ciprofloxacin-sulfonamide hybrids to manipulate ciprofloxacin pharmacological qualities: Potency and side effects., 228 [PMID:34871841 ] [10.1016/j.ejmech.2021.114021 ]